Abstract. The Radioimmunoassay of ß-endorphin. ß-Endorphini was quantified by using an antiserum that was raised in rabbits against human ß-LPH as described by Jackson & Lowry (1980 (1.27 ± 0.13 pg per lobe, N = 10, and 1.14 ± 0.08 pg per lobe, N = 10, respectively), and the total amount of a-MSH¡ released during 2 h of superfusion with KRB was less than 5% of the a-MSH content of the NIL after superfusion.
1. neurointermediate lobes of rats secrete spontaneously various ACTH-and LPH-related peptides in amounts proportional to the amounts in which these peptides are found in extracts of the neurointermediate lobe; 2. the \g=b\-adrenergicagonist, isoproterenol, stimulated the spontaneous release of various peptides, including \g=a\-MSH,ACTH, CLIP, glycosylated CLIP, and \g=b\-endorphin-like peptides; 3. isoproterenol induced a dose-dependent (10\ m=-\ 9\ p=n-\ 10\ m=-\ 7 m), parallel increase in the release of \g=a\-MSHand ACTH following similar time courses and showing indentical EC50 values (about 10\m=-\8m).
Although the spontaneous release of \g=a\-MSHand ACTH from rat neurointermediate lobes is not strictly coupled under the conditions used in this study, isoproterenol seems to affect the spontaneous release of these peptides to the same relative extent.
A series of biologically active peptides related to ACTH and LPH are (Mains et al. 1977 ; Roberts & Herbert 1977; Rubinstein et al. 1978; Nakanishi et al. 1979) .
Although the precursor produced in the cortico¬ trophs is likely to be identical to that formed in the melanotrophs (Mains & Eipper 1975  Eipper & Mains 1978) (Mulder & Smelik 1977 For the quantification of a-MSH¡ in fractions obtained after column chromatography, we used the a-MSH assay described by Scott et al. (1976) . Both a-MSH assays show similar characteristics.
Radioimmunoassays of ACTH. ACTH¡ was quantified by using the NH2-terminal and the CO^H-terminal ACTH assays desbribed elsewhere in detail (Ratcliffe et al. 1972 ).
In both assays, ACTH 1-39 was used as a standard and for labelling purposes. In the C02H-terminal assay, a-MSH did not crossreact, but CLIP showed full crossreaction with ACTH 1.39. In the NH2-terminal assay, CLIP did not crossreact, and a-MSH showed only a slight crossreaction with h-ACTH 1.39.
Radioimmunoassay of ß-endorphin. ß-Endorphini was quantified by using an antiserum that was raised in rabbits against human ß-LPH as described by Jackson & Lowry (1980 
Results
Spontaneous release ofACTH), and a-MSHj During superfusion of rat NIL with KRB, the release of a-MSH¡ was initially high but fell rapidly, which is in agreement with a previous report of MSH bioactivity (1.27 ± 0.13 pg per lobe, N = 10, and 1.14 ± 0.08 pg per lobe, N = 10, respectively), and the total amount of a-MSH¡ released during 2 h of superfusion with KRB was less than 5% of the a-MSH content of the NIL after superfusion. 
120
(min) When propranolol (10~7 M) was present through¬ out the superfusion experiment, the a-MSHi and ACTHb releasing effects of 10"8 M isoproterenol were completely blocked and those of 10"7 M iso¬ proterenol were partially prevented.
Chromatography of ACTH-and LPH-related peptides released spontaneously Superfusion medium samples were subjected to chromatography on Sephadex G-50, and the eluted fractions were analyzed by using four different radioimmunoassay systems as shown in Fig. 4 (Jackson & Lowry 1980) . Peak II had the same elution volume as CLIP.
Most of the ß-endorphini was present in two major peaks, reflecting the situation in NIL ex¬ tracts (Jackson & Lowry 1980) . The first peak, 'ß-endorphini I,' had the same elution volume as ß-endorphin, whereas the second peak, 'ß-endor- (Jackson & Lowry 1980) . The sub¬ stance^) appearing as ß-endorphini I (cf. Fig. 4 (Fig. 4) (Stoeckel et al. 1973 ). Alternatively, it may be a consequence of differences in subcellular compartmentalization related to the fact that ACTH is an intermediate in the biosynthesis of a-MSH and CLIP, rather than a major end product in the intermediate lobe.
In view of the latter hypothesis, it was of interest to establish whether catecholamines that are known to affect the release of a-MSH in vitro and in vivo would have similar effects on the release of other ACTH-and LPH-related peptides.
In addition to the MSH-release-inhibiting effects of dopamine and of high concentrations of epinephrine and norepinephrine (Hadley et al. 1977) which are probably mediated by interaction of these catecholamines with dopamine receptors (Tilders et al. 1980b ), low dose of epinephrine have
